Request Copyright Permission

A Multi-Stakeholder Approach to Minimizing the Environmental Impact of Inhaled Therapies and Improving Patient Care

Lewis H, Hardwick M, Rignall A.

Respiratory Drug Delivery 2021. Volume , 2021: 45-56.

Abstract:

It is recognized that healthcare makes a significant contribution to the overall global carbon footprint. Energy, transportation, supply chain, estates, usage and disposal of medicines all have climate impact. Inhaled medicines form part of this contribution and in this context, the need to improve patient care whilst, in parallel, minimize the environmental impact of inhaled therapies is clear. In particular, the environmental impact of the propellants used in pressurized metered dose inhalers (pMDIs) continues to be a particular focus for global and regional legislation and in national healthcare guidelines, policy, or recommendations.

Healthcare interventions and improvements that positively interact with the patient are the most effective, so a multi-stakeholder approach to minimizing the environmental impact of inhaled therapies, in parallel with improving patient care, is recommended. Engaging patients, healthcare providers, health authorities, environmental agencies and administrative bodies is considered the best approach to balancing patient needs and environmental issues. A case study in the United Kingdom (UK) exemplifying this approach is provided.